Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PROspective Renal Cancer Cohort (PRO-RCC)

NCT05326620 is registered in ClinicalTrials.gov with PROspective Renal Cancer Cohort Foundation as lead sponsor.

NCT NCT05326620
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05326620 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PROspective Renal Cancer Cohort (PRO-RCC)
Lead sponsor
PROspective Renal Cancer Cohort Foundation
Phase
Observational
Overall status
Recruiting
Start date
January 19, 2023
Completion date
January 31, 2030
Enrollment
2,000 (estimated)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

renal cancer, renal cell cancer metastatic, renal cell carcinoma